StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research report report published on Wednesday morning. The brokerage issued a sell rating on the stock.
Ampio Pharmaceuticals Price Performance
Shares of AMPE stock opened at $0.00 on Wednesday. The firm has a market cap of $2,383.50, a P/E ratio of 0.00 and a beta of 3.73. Ampio Pharmaceuticals has a twelve month low of $0.00 and a twelve month high of $0.70.
Ampio Pharmaceuticals Company Profile
Featured Stories
- Five stocks we like better than Ampio Pharmaceuticals
- The Most Important Warren Buffett Stock for Investors: His Own
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- These 3 Stocks Have Huge Last 12 Months Shareholder Yields
- Investing in Commodities: What Are They? How to Invest in Them
- Prominent Hedge Fund Acquires Huge Stake in HPE: Is It a Buy Now?
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
